Literature DB >> 3078050

Expressed emotion research in schizophrenia: theoretical and clinical implications.

L Kuipers1, P Bebbington.   

Abstract

The expressed emotion (EE) measure is a robust predictor of relapse in schizophrenia. At least twelve studies from a range of cultures have now shown this, although the authors of one maintain their findings are the result of confounding factors. A thirteenth study which failed to demonstrate a predictive effect was seriously weakened by methodological defects. There is now also evidence for the construct validity of EE, which has been shown to reflect ongoing family interactions. High EE relatives display less effective coping responses, and may adversely affect the patient by creating an unpredictable environment. EE may change with time, and probably reflects the interaction of external stresses, the real problems with the patient, and inappropriate coping responses. The association of high EE with arousal in the patient, as indicated by skin conductance abnormalities, has now been replicated. Although the EE phenomenon can be subsumed under a vulnerability-stress model, the way in which it might mediate relapse has not as yet been specified. Interventions have been successful in reducing relapse, and do so by increasing the tolerance and coping skills of the relatives, and by establishing more realistic expectations. As most have also involved the patient in the process of treatment, they have not fully resolved the question of causal direction. Future studies will clarify these issues, but will not detract from the value that EE has already had in energizing research. It has also provided a framework within which clinicians have begun to recognize and deal with the disabling problems that beset schizophrenic patients and their families.

Entities:  

Mesh:

Year:  1988        PMID: 3078050     DOI: 10.1017/s0033291700009831

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  22 in total

1.  Prognosis for schizophrenia in the Third World: a reevaluation of cross-cultural research.

Authors:  A Cohen
Journal:  Cult Med Psychiatry       Date:  1992-03

2.  Expressed Emotion in families of chronic schizophrenics and its association with clinical measures.

Authors:  V G Mavreas; V Tomaras; V Karydi; M Economou; C N Stefanis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

3.  A Portuguese/Brazilian study of Expressed Emotion.

Authors:  C Martins; A I de Lemos; P E Bebbington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

4.  Comment on paper by Cohen, Patel, Thara, and Gureje.

Authors:  Julian Leff
Journal:  Schizophr Bull       Date:  2008-01-21       Impact factor: 9.306

5.  Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort.

Authors:  Guilherme Polanczyk; Terrie E Moffitt; Louise Arseneault; Mary Cannon; Antony Ambler; Richard S E Keefe; Renate Houts; Candice L Odgers; Avshalom Caspi
Journal:  Arch Gen Psychiatry       Date:  2010-04

6.  The 'ward-in-a-house': residential care for the severely disabled.

Authors:  G Shepherd
Journal:  Community Ment Health J       Date:  1995-02

7.  The needs of high and low expressed emotion families: a normative approach.

Authors:  J Smith; M Birchwood; R Cochrane; S George
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-02       Impact factor: 4.328

Review 8.  Family burden in schizophrenia: implications for services.

Authors:  L Kuipers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-10       Impact factor: 4.328

9.  Rejection of chronic schizophrenic patients : some preliminary observations from kerala.

Authors:  L S Manickam; S R Chandran
Journal:  Indian J Psychiatry       Date:  1998-07       Impact factor: 1.759

10.  Community care for patients with schizophrenia one year after hospital discharge.

Authors:  D Melzer; A S Hale; S J Malik; G A Hogman; S Wood
Journal:  BMJ       Date:  1991-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.